FATE
$34.07
Fate Therapeutics
($.63)
(1.82%)
FATE
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.30)
Revenue:  N/A
Wednesday
Nov 4
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when FATE reports earnings?
Beat
Meet
Miss

Where is FATE's stock price going from here?
Up
Flat
Down
Stock chart of FATE
Analysts
Summary of analysts' recommendations for FATE
Score
Grade
Pivots
Resistance
$38.22
$37.48
$36.09

$35.35

Support
$33.96
$33.22
$31.83
Tweet
Growth
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalJohnson & JohnsonZoetisBristol-Myers SquibbUltragenyx PharmaceuticalCatalentMerck & Co.